The CA19-9 >37 U/ml was more often in the ICC patients than in the cHCC-CCA or ICC patients, while the AFP >20 ng/ml was more often in the HCC and cHCC-CCA than ICC (all P<0.001). The gene discussed is AFP; the disease is intrahepatic cholangiocarcinoma.